These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8184487)

  • 1. Cholecystokinin and morphine analgesia: variations on a theme.
    Stanfa L; Dickenson A; Xu XJ; Wiesenfeld-Hallin Z
    Trends Pharmacol Sci; 1994 Mar; 15(3):65-6. PubMed ID: 8184487
    [No Abstract]   [Full Text] [Related]  

  • 2. CCK-B antagonists exhibit antidepressant-like effects and potentiate endogenous enkephalin analgesia. Correlation with in vivo binding affinities and brain penetration.
    Durieux C; Derrien M; Maldonado R; Valverde O; Blommaert A; Fournié-Zaluski MC; Roques BP
    Ann N Y Acad Sci; 1994 Mar; 713():355-7. PubMed ID: 8185186
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cholecystokinin receptor antagonists].
    Ohtsuka T; Yokose K
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1853-62. PubMed ID: 8210429
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems.
    Kissin I; Bright CA; Bradley EL
    Anesth Analg; 2000 Jul; 91(1):110-6. PubMed ID: 10866896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists.
    Patel S; Chapman KL; Smith AJ; Heald A; Freedman SB
    Ann N Y Acad Sci; 1994 Mar; 713():360-3. PubMed ID: 8185188
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF; Hewett K; Dickenson AH
    Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia.
    Wiertelak EP; Maier SF; Watkins LR
    Science; 1992 May; 256(5058):830-3. PubMed ID: 1589765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats.
    Valverde O; Roques BP
    Neurosci Lett; 1998 Mar; 244(1):37-40. PubMed ID: 9578139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CholecystokininB receptor antagonist increases food intake in rats.
    Dorré D; Smith GP
    Physiol Behav; 1998 Aug; 65(1):11-4. PubMed ID: 9811359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin.
    Rady JJ; Lin W; Fujimoto JM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):878-85. PubMed ID: 9495845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
    Coudoré-Civiale MA; Courteix C; Boucher M; Méen M; Fialip J; Eschalier A; Ardid D
    Neurosci Lett; 2000 May; 286(1):37-40. PubMed ID: 10822147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: electrophysiological and behavioural studies.
    Xu XJ; Hoffmann O; Wiesenfeld-Hallin Z
    Neuropeptides; 1996 Apr; 30(2):203-6. PubMed ID: 8771563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
    Yamamoto T; Sakashita Y
    Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
    Pu SF; Han JS
    Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
    Hoffmann O; Wiesenfeld-Hallin Z
    Neuroreport; 1994 Dec; 5(18):2565-8. PubMed ID: 7696605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress reduces morphine's antinociceptive potency: dependence upon spinal cholecystokinin processes.
    Hawranko AA; Smith DJ
    Brain Res; 1999 Apr; 824(2):251-7. PubMed ID: 10196456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-promoting effects of glycine-extended progastrin.
    Seva C; Dickinson CJ; Yamada T
    Science; 1994 Jul; 265(5170):410-2. PubMed ID: 8023165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites.
    Branchereau P; Champagnat J; Roques BP; Denavit-Saubie M
    Neuroreport; 1992 Oct; 3(10):909-12. PubMed ID: 1330059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.